Reduced encephalopathy in pigs with ischemia-induced acute hepatic failure treated with a bioartificial liver containing alginate-entrapped hepatocytes.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Critical Care Medicine

• Publication date

  2002-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00003246-200203000-00027PMID 11990930
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term cultures of adult mammalian hepatocytes in hollow fibers as the cellular component of extracorporeal (hybrid) liver assist devices.

  2008cited by this paper
• Improved liver function following treatment with an extracorporeal liver assist device.

  2008cited by this paper
• Viability and drug metabolism capacity of alginate-entrapped hepatocytes after cryopreservation

  2004cited by this paper
• A reversible model of acute hepatic failure by temporary hepatic ischemia in the pig.

  2000cited by this paper
• Bioartificial liver support system using porcine hepatocytes entrapped in a three-dimensional hollow fiber module with collagen gel: An evaluation in the swine acute liver failure model.

  1999cited by this paper
• Detoxifying activity in pig livers and hepatocytes intended for xenotherapy.

  1999cited by this paper
• Long-term liver cell cultures in bioreactors and possible application for liver support

  1997cited by this paper
• Fulminant hepatic failure.

  1997cited by this paper
• Survival, proliferation, and functions of porcine hepatocytes encapsulated in coated alginate beads: a step toward a reliable bioartificial liver.

  1997cited by this paper
• Artificial liver support.

  1996cited by this paper
• Preclinical trial of a bioartificial liver support system in a porcine fulminant hepatic failure model.

  1996cited by this paper
• Pilot‐controlled trial of the extracorporeal liver assist device in acute liver failure

  1996cited by this paper
• Influence of alginate gel entrapment and cryopreservation on survival and xenobiotic metabolism capacity of rat hepatocytes.

  1996cited by this paper
• An anesthetized model of lethal canine galactosamine fulminant hepatic failure

  1995cited by this paper
• Fulminant hepatic failure: Summary of a workshop

  1995cited by this paper
• Early clinical experience with a hybrid bioartificial liver.

  1995cited by this paper
• Orthotopic Liver Transplantation in Fulminant and Subfulminant Hepatitis The Paul Brousse Experience

  1995cited by this paper
• The hepatix extracorporeal liver assist device in the treatment of fulminant hepatic failure.

  1994cited by this paper
• Hepatocyte Culture between Three Dimensionally Arranged Biomatrix-Coated Independent Artificial Capillary Systems and Sinusoidal Endothelial Cell Co-Culture Compartments

  1994cited by this paper
• A Bioartificial Liver to Treat Severe Acute Liver Failure

  1994cited by this paper
• The Hepatix extracorporeal liver assist device: initial clinical experience.

  1994cited by this paper
• Correction of Bilirubin Conjugation in the Gunn Rat Using Hepatocytes Immobilized in Alginate Gel Beads as an Extracorporeal Bioartificial Liver

  1993cited by this paper
• Development of a bioartificial liver: Properties and function of a hollow‐fiber module inoculated with liver cells

  1993cited by this paper
• Extracorporeal liver assist device (ELAD): a preliminary report.

  1993cited by this paper
• An improved model of acetaminophen‐induced fulminant hepatic failure in dogs

  1992cited by this paper
• Artificial Liver Support

  1992cited by this paper
• Hepatocyte function in a hollow fiber bioreactor: a potential bioartificial liver.

  1992cited by this paper
• Intensive liver care and management of acute hepatic failure

  1991cited by this paper
• Perioperative management of fulminant and subfulminant hepatic failure with therapeutic plasmapheresis.

  1989cited by this paper
• Hepatotoxicity of D-galactosamine in the isolated perfused rat liver.

  1980cited by this paper
• Intracranial pressure in pigs with surgically induced acute liver failure.

  1979cited by this paper
• Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane.

  1978cited by this paper
• Biochemical correlates of reversal of hepatic coma coated with charcoal hemoperfusion.

  1978cited by this paper
• An animal model of fulminant hepatic failure: a feasibility study.

  1976cited by this paper
• DEANOL IN SPONTANEOUS AND INDUCED DYSKINESIAS

  1975cited by this paper
• The anhepatic model in a pig.

  1974cited by this paper
• Charcoal haemoperfusion in the treatment of fulminant hepatic failure.

  1974cited by this paper
• Treatment of hepatic coma in cirrhosis by plasmapheresis and plasma infusion (plasma exchange).

  1968cited by this paper
• A simple extracorporeal device for reducing elevated blood ammonia levels; preliminary report.

  1958cited by this paper

• Bioartificial livers: a review of their design and manufacture

  2022cites this paper
• Industrial Enzymes

  2021cites this paper
• A bioartificial liver support system integrated with a DLM/GelMA-based bioengineered whole liver for prevention of hepatic encephalopathy via enhanced ammonia reduction.

  2020cites this paper
• Alginate-Based Cell Microencapsulation for Tissue Engineering and Regenerative Medicine.

  2017cites this paper
• A New Fluidized Bed Bioreactor Based on Diversion-Type Microcapsule Suspension for Bioartificial Liver Systems

  2016cites this paper
• Amélioration des résultats de la thérapie cellulaire hépatique : Développement d’une nouvelle méthode de préparation du foie receveur et développement d’une source cellulaire alternative aux hépatocytes

  2015cites this paper
• Endotoxinämie im Akuten Leberversagen am Grosstiermodell

  2015cites this paper
• Development of a bioreactor based on magnetically stabilized fluidized bed for bioartificial liver

  2015cites this paper
• Effect of plasma components on the stability and permeability of microcapsule.

  2014cites this paper
• Microencapsulation and Bioreactors for Liver Support

  2013cites this paper
• Transplantation d'hépatocytes génétiquement modifiés : régénération hépatique et moyens d'amélioration de la prise de greffe hépatocytaire

  2012cites this paper
• Studies of human and porcine hepatocyte cryopreservation and their suitability for use in bioartificial liver development

  2012cites this paper
• Bioartificial liver system based on choanoid fluidized bed bioreactor improve the survival time of fulminant hepatic failure pigs

  2011cites this paper
• Clinical Uses of Alginate

  2011cites this paper
• Standardized intensive care unit management in an anhepatic pig model: new standards for analyzing liver support systems

  2010cites this paper
• A Model of Ischemic Isolated Acute Liver Failure in Pigs: Standardizing Monitoring and Treatment

  2010cites this paper
• Hepatocyte transplantation in animal models

  2009cites this paper
• Evaluation of liver support systems for preclinical testing by animal trials.

  2006cites this paper
• Hepatocytes cultured in alginate microspheres: an optimized technique to study enzyme induction.

  2005cites this paper
• Photodynamic Actinometry Using Microspheres: Concept, Development and Responsivity¶

  2004cites this paper
• Photodynamic Actinometry Using Microspheres: Concept, Development and Responsivity ¶

  2004cites this paper
• Obstetric and gynaecological anaesthesia

  2003cites this paper
• Hypothermic Storage and Cryopreservation of Hepatocytes: The Protective Effect of Alginate Gel against Cell Damages

  2003cites this paper
• Alterations in bronchoalveolar lavage fluid during ischemia‐induced acute hepatic failure in the pig

  2003cites this paper
• Method for monitoring alginate released in biological fluids by high-performance anion-exchange chromatography with pulsed amperometric detection.

  2003cites this paper
• Follow‐up by one‐ and two‐dimensional NMR of plasma from pigs with ischemia‐induced acute liver failure treated with a bioartificial liver

  2002cites this paper